Key Laboratory of Smart Drug Delivery, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.
State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases Xijing Hospital Air Force Medical University, Xian, China.
Cancer Biother Radiopharm. 2023 Nov;38(9):641-649. doi: 10.1089/cbr.2021.0251. Epub 2021 Nov 12.
This study investigated the raltitrexed loading method, compatible stability with contrast agent, release profiles, and morphological properties of CalliSpheres, DC Bead, and HepaSphere. The amounts of raltitrexed added, loading medium, loading condition, and drug concentrations were investigated as factors influencing drug loading efficiency. Compatible stability with iopamidol was tested. Release profiles were accessed by a flowthrough apparatus system. Morphological properties were evaluated by a scanning electron microscope (SEM). Diameters were measured by a laser diffraction particle size analyzer. With the optimized method, the amount of raltitrexed loading to a marketed drug-eluting beads (DEBs) package was 2.67 mg for CalliSpheres, 2.34 mg for DC Bead, and 3.19 mg for HepaSphere. For all three DEBs, the drug leak rate was >50% within 2 h after mixing with iopamidol, and the time to reach 75% of the release plateau was within 10 min. Diameters increased after drug loading. Drug crystals were observed on the surface of DEBs in SEM. The amount of drug loading could meet clinical requirements by the optimized method. All three raltitrexed-loaded DEBs showed poor compatible stability with iopamidol, as well as rapid drug release performance, which should be noticed in clinical practice.
本研究考察了雷替曲塞的加载方法、与对比剂的相容性稳定性、释放特性以及 CalliSpheres、DC Bead 和 HepaSphere 的形态特性。考察了添加的雷替曲塞量、加载介质、加载条件和药物浓度等因素对药物载药效率的影响。测试了与碘帕醇的相容性稳定性。通过流通式装置系统评估释放特性。通过扫描电子显微镜(SEM)评估形态特性。通过激光衍射粒度分析仪测量粒径。采用优化方法,向市售载药微球(DEBs)包载的雷替曲塞量为 CalliSpheres 为 2.67mg,DC Bead 为 2.34mg,HepaSphere 为 3.19mg。对于所有三种 DEBs,与碘帕醇混合后 2 小时内药物泄漏率>50%,达到释放平台 75%所需的时间在 10 分钟内。载药后粒径增大。SEM 观察到 DEBs 表面有药物晶体。通过优化方法可以满足临床需求的载药量。三种载雷替曲塞的 DEBs 与碘帕醇均显示出较差的相容性稳定性,以及快速的药物释放性能,在临床实践中应予以注意。